Search results
Jun 12, 2024 · NanoString is now a Bruker company that offers comprehensive research solutions for spatial biology, including nCounter, GeoMx, CosMx, and AtoMx platforms. Learn how to translate scientific discoveries into actionable gene expression insights, spatially profile the whole transcriptome and 150+ protein targets, and leverage the cloud for spatial data analysis and visualization.
- Products
NanoString is the leader in spatial biology. Find the...
- Company
As the pioneer in the field of spatial biology, NanoString...
- Single Cells, Giant Leaps
NanoString scientist LiuLiu Pan, PhD, discusses GeoMx DSP...
- Join Our Team
At NanoString, we empower our employees and encourage them...
- Investors
NanoString Technologies, a leader in spatial biology, offers...
- nCounter Analysis System
nCounter® Analysis Systems for Biomarker Validation and...
- GeoMx Digital Spatial Profiler
GeoScript Hub enables easy access to the latest spatial...
- Neuroscience
nCounter® miRGE Assay Simultaneously detect mRNAs and miRNAs...
- Products
NanoString Technologies, Inc. is a biotech company offering discovery and translational research solutions. NanoString's products include the nCounter Gene Expression System, the GeoMx Digital Spatial Profiler, the CosMx Spatial Molecular Imager, and the AtoMx Spatial Informatics Platform.
NanoString is a company that develops and sells products based on digital molecular barcoding technology for gene expression and spatial profiling of RNA and protein targets. Learn about their mission, history, platforms, and career opportunities.
nCounter is a platform for multiplexing up to 800 gene expression targets using direct detection technology. It offers flexible assays, robust performance, and efficient workflow for biomarker validation and development in various fields of study.
Apr 17, 2024 · Bruker Wins Competitive Auction. Acquisition Ensures Continued Customer Access to NanoString’s Products. Transaction Expected to Close in early-May 2024. SEATTLE-- (BUSINESS WIRE)-- NanoString Technologies, Inc. (“NanoString” or “the Company”), a leading provider of life science tools for discovery and translational research, today ...
Apr 17, 2024 · NanoString, a provider of life science tools for discovery and translational research, announced that it will be sold to Bruker for $392.6 million in cash and liabilities. The transaction is expected to close in early-May 2024 and will end NanoString's chapter 11 restructuring process.
Mar 27, 2024 · NanoString Technologies, a leader in spatial biology, offers an ecosystem of innovative discovery and translational research solutions, empowering our customers to map the universe of biology.